Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study

IntroductionAnemia among the critically ill has been described in patients with short to medium length of stay (LOS) in the intensive care unit (ICU), but it has not been described in long-stay ICU patients. This study was performed to characterize anemia, transfusion, and phlebotomy practices in patients with prolonged ICU LOS.MethodsWe conducted a retrospective chart review of consecutive patients admitted to a medical-surgical ICU in a tertiary care university hospital over three years; patients included had a continuous LOS in the ICU of 30 days or longer. Information on transfusion, phlebotomy, and outcomes were collected daily from days 22 to 112 of the ICU stay.ResultsA total of 155 patients were enrolled. The mean age, admission Acute Physiology and Chronic Health Evaluation II score, and median ICU LOS were 62.3 ± 16.3 years, 23 ± 8, and 49 days (interquartile range 36–70 days), respectively. Mean hemoglobin remained stable at 9.4 ± 1.4 g/dl from day 7 onward. Mean daily phlebotomy volume was 13.3 ± 7.3 ml, and 62% of patients received a mean of 3.4 ± 5.3 units of packed red blood cells at a mean hemoglobin trigger of 7.7 ± 0.9 g/dl after day 21. Transfused patients had significantly greater acuity of illness, phlebotomy volumes, ICU LOS and mortality, and had a lower hemoglobin than did those who were not transfused. Multivariate logistic regression analysis identified the following as independently associated with the likelihood of requiring transfusion in nonbleeding patients: baseline hemoglobin, daily phlebotomy volume, ICU LOS, and erythropoietin therapy (used almost exclusively in dialysis dependent renal failure in this cohort of patients). Small increases in average phlebotomy (3.5 ml/day, 95% confidence interval 2.4–6.8 ml/day) were associated with a doubling in the odds of being transfused after day 21.ConclusionAnemia, phlebotomy, and transfusions, despite low hemoglobin triggers, are common in ICU patients long after admission. Small decreases in phlebotomy volume are associated with significantly reduced transfusion requirements in patients with prolonged ICU LOS.

[1]  M. Levy,et al.  Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. , 2002, JAMA.

[2]  M. Levy,et al.  The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States* , 2004, Critical care medicine.

[3]  K. Eckardt,et al.  Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients* , 1999, Critical care medicine.

[4]  T. Walsh,et al.  Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice , 2005, Intensive Care Medicine.

[5]  M. Suistomaa,et al.  Customised prediction models based on APACHE II and SAPS II scores in patients with prolonged length of stay in the ICU , 2002, Intensive Care Medicine.

[6]  D. Cook,et al.  Do blood transfusions improve outcomes related to mechanical ventilation? , 2001, Chest.

[7]  K. Gubler,et al.  Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial* , 2001, Critical care medicine.

[8]  B. Kavanagh,et al.  Utilization of intensive care unit days in a Canadian medical-surgical intensive care unit. , 1999, Critical care medicine.

[9]  S. Kleinman,et al.  A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care , 1999 .

[10]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[11]  K. Gubler,et al.  Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial , 1998 .

[12]  Yaseen Arabi,et al.  A prospective study of prolonged stay in the intensive care unit: predictors and impact on resource utilization. , 2002, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[13]  J. Vincent,et al.  Anemia and blood transfusion in critically ill patients. , 2002, JAMA.

[14]  V. Hillier,et al.  Blood gas analysis: a study of blood loss in intensive care. , 1999, Journal of advanced nursing.

[15]  S. Brett,et al.  Blood component use in critically ill patients , 2002, Anaesthesia.

[16]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[17]  J. Friedrich,et al.  Long-term outcomes and clinical predictors of hospital mortality in very long stay intensive care unit patients: a cohort study , 2006, Critical care.

[18]  H. Corwin,et al.  RBC transfusion in the ICU. Is there a reason? , 1995, Chest.

[19]  R. Bellomo,et al.  Appropriateness of red blood cell transfusion in Australasian intensive care practice , 2002, The Medical journal of Australia.

[20]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.